Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Malignant Lymphoma

  Free Subscription


1 Am Surg
3 Blood
3 Br J Haematol
1 Haematologica
1 J Clin Oncol
1 J Natl Cancer Inst
1 Leuk Lymphoma
1 N Engl J Med
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am Surg

  1. REZKALLAH E, Hanna RS, Elsaify WM
    Thyroid Lymphoma: Case Series Review.
    Am Surg. 2022 Jun 27:31348221111512. doi: 10.1177/00031348221111512.
    PubMed         Abstract available


  2. PAREKH A, Keller FG, McCarten KM, Kessel S, et al
    Targeted Radiotherapy for Early-Stage Low-Risk Pediatric Hodgkin Lymphoma Slow Early Responders: A COG AHOD0431 Analysis.
    Blood. 2022 Jun 28. pii: 485708. doi: 10.1182/blood.2022016098.
    PubMed         Abstract available

  3. PINDZOLA GM, Razzaghi R, Tavory RN, Nguyen HT, et al
    Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphoma.
    Blood. 2022 Jun 27. pii: 485703. doi: 10.1182/blood.2022015926.
    PubMed         Abstract available

  4. IZQUIERDO E, Vorholt D, Blakemore S, Sackey B, et al
    Extracellular vesicles and PD-L1 suppress macrophages, inducing therapy resistance in TP53-deficient B-cell malignancies.
    Blood. 2022;139:3617-3629.
    PubMed         Abstract available

    Br J Haematol

  5. SHARGIAN L, Raanani P, Yeshurun M, Gafter-Gvili A, et al
    Chimeric antigen receptor T-cell therapy is superior to standard of care as second-line therapy for large B-cell lymphoma: A systematic review and meta-analysis.
    Br J Haematol. 2022 Jun 28. doi: 10.1111/bjh.18335.
    PubMed         Abstract available

  6. KAWASAKI N, Nishito Y, Yoshimura Y, Yoshiura S, et al
    The molecular rationale for the combination of polatuzumab vedotin plus rituximab in diffuse large B-cell lymphoma.
    Br J Haematol. 2022 Jun 28. doi: 10.1111/bjh.18341.
    PubMed         Abstract available

  7. KATAYAMA S, Hiraishi T, Ota M
    Skin manifestations of intravascular adult T-cell leukaemia/lymphoma.
    Br J Haematol. 2022 Jun 27. doi: 10.1111/bjh.18318.


  8. KWON M, Iacoboni G, Reguera JL, Corral LL, et al
    Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma.
    Haematologica. 2022 Jun 30. doi: 10.3324/haematol.2022.280805.
    PubMed         Abstract available

    J Clin Oncol

  9. MARTIN P, Cohen JB, Wang M, Kumar A, et al
    Treatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World Cohorts.
    J Clin Oncol. 2022 Jun 28:JCO2102698. doi: 10.1200/JCO.21.02698.
    PubMed         Abstract available

    J Natl Cancer Inst

  10. ROBERTI S, van Leeuwen FE, Ronckers CM, Krul IM, et al
    Radiotherapy-related dose and irradiated volume effects on breast cancer risk among Hodgkin lymphoma survivors.
    J Natl Cancer Inst. 2022 Jun 30. pii: 6623416. doi: 10.1093.
    PubMed         Abstract available

    Leuk Lymphoma

  11. STUVER R, Lewis NE, Ewalt MD, Dogan A, et al
    First report of bilateral breast-implant associated anaplastic large cell lymphoma caused by identical T-cell clone.
    Leuk Lymphoma. 2022 Jun 25:1-4. doi: 10.1080/10428194.2022.2092860.

    N Engl J Med

  12. ARMITAGE JO, Longo DL
    Mantle-Cell Lymphoma.
    N Engl J Med. 2022;386:2495-2506.

    Proc Natl Acad Sci U S A

  13. CACCURI F, Messali S, Zani A, Campisi G, et al
    HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide.
    Proc Natl Acad Sci U S A. 2022;119:e2122050119.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.